71 research outputs found
Adverse effects of pegaspargase in pediatric patients receiving doses greater than 3,750Ā IU
BackgroundIncreased toxicities have been identified with higher doses of pegaspargase (PEGāASP) in adults. This has led to routine use of a dose cap of 3,750Ā IU for adult acute lymphoblastic leukemia (ALL) patients in most institutions. In pediatric ALL patients, PEGāASP is not capped. There is concern at our institution that larger doses may result in increased rates of adverse effects and that increased monitoring may be warranted in pediatric patients receiving doses greater than 3,750Ā IU. The objective of this study is to quantify the difference in the rates of PEGāASPāassociated adverse events between pediatric patients who received doses greater than 3,750Ā IU and less than or equal to 3,750Ā IU.MethodsRetrospective chart review of patients 1ā21 years old with preāBācell ALL who received PEGāASP between 2007 and 2014 at an academic medical center.ResultsOf 183 patients included in the analysis, 24 received PEGāASP doses higher than 3,750Ā IU and 159 received doses less than or equal to 3,750Ā IU. The incidence of venous thromboembolism (VTE) was significantly higher for patients in the group that received more than 3,750Ā IU compared with those who received 3,750Ā IU or less (20.8 vs. 1.89%, respectively; P = 0.0011). The incidence of pancreatitis (P = 0.0306) and hyperglycemia (P = 0.0089) were also higher in the group that received more than 3,750Ā IU.ConclusionsPEGāASP doses higher than 3,750Ā IU are associated with higher rates of VTE, pancreatitis, and hyperglycemia in pediatric patients with preāBācell ALL. Patients receiving more than 3,750Ā IU should have increased monitoring, and larger, multicenter trials are needed to determine if monitoring, VTE prophylaxis, and potential dose capping recommendations should be added to clinical trial protocols.Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/138220/1/pbc26555_am.pdfhttps://deepblue.lib.umich.edu/bitstream/2027.42/138220/2/pbc26555.pd
Recommended from our members
Think Again ā Supplying War: Reappraising Military Logistics and Its Centrality to Strategy and War
This article argues that logistics constrains strategic opportunity while itself being heavily circumscribed by strategic and operational planning. With the academic literature all but ignoring the centrality of logistics to strategy and war, this article argues for a reappraisal of the critical role of military logistics, and posits that the study and conduct of war and strategy are incomplete at best or false at worst when they ignore this crucial component of the art of war. The article conceptualises the logisticsāstrategy nexus in a novel way, explores its contemporary manifestation in an age of uncertainty, and applies it to a detailed case study of UK operations in Iraq and Afghanistan since 2001
- ā¦